Company / Capital Returned to Shareholders per Share
Harmony Biosciences Holdings, Inc. Capital Returned to Shareholders per Share History
FY2020-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$1.68
FY2023
5-year range
$0.00 / $1.68
FY2020-FY2023
Trend
-
vs FY2022
Sector context
#19 of 51
Health Care
What the data says
Capital Returned to Shareholders per Share changed +57043% YoY in FY2023, a notable deviation from the 2-year average annual change of +28478%.
Based on SEC 10-K filings.
1.68 in FY2023.
Improved from $0.02 to $1.68 over the past 3 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- +327.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#19 of 51 in Health CareTop 37% of 51This company $1.68 Sector average $2.74
▼
-38.7% below sector average
Key checks
Key Insights
- Ranks #19 out of 51 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 20.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $1.68 | - |
| FY2022 | - | - |
| FY2021 | $0.00 | -86.3% |
| FY2020 | $0.02 | - |
| FY2019 | - | - |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026